Research Output per year
Personal profile
Training Experience
| 2015 | Internship, Advocate Christ Medical Center/Advocate Children's Hospital |
| 2015 | Residency, Advocate Children's Hospital, Oak Lawn |
| 2018 | Fellowship, Northwestern University, McGaw Medical Center (Lurie Children's Hospital) |
| 2019 | Fellowship, Northwestern University, McGaw Medical Center (Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois |
Education/Academic qualification
MD, Brown University
… → 2011
Fingerprint Dive into the research topics where Alicia Lenzen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Glioblastoma
Medicine & Life Sciences
Indoleamine-Pyrrole 2,3,-Dioxygenase
Medicine & Life Sciences
Vaccines
Medicine & Life Sciences
Pediatrics
Medicine & Life Sciences
Kynurenine
Medicine & Life Sciences
Thrombasthenia
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Central Nervous System Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2015 2018
Clinical Trials 101 in Pediatric Oncology Patients
Lenzen, A. & Smiley, N. P., Jun 1 2018, In : Clinical Pediatric Emergency Medicine. 19, 2, p. 131-134 4 p.Research output: Contribution to journal › Article
Clinical Trials
Pediatrics
Hospital Emergency Service
Therapeutics
Neoplasms
24
Citations
(Scopus)
IDO1 in cancer: a Gemini of immune checkpoints
Zhai, L., Ladomersky, E., Lenzen, A., Nguyen, B., Patel, R., Lauing, K. L., Wu, M. & Wainwright, D. A., May 1 2018, In : Cellular and Molecular Immunology. 15, 5, p. 447-457 11 p.Research output: Contribution to journal › Review article
Indoleamine-Pyrrole 2,3,-Dioxygenase
Neoplasms
Tryptophan
Kynurenine
Essential Amino Acids
18
Citations
(Scopus)
IDO1 inhibition synergizes with radiation and PD-1 blockade to durably increase survival against advanced glioblastoma
Ladomersky, E., Zhai, L., Lenzen, A., Lauing, K. L., Qian, J., Scholtens, D. M., Gritsina, G., Sun, X., Liu, Y., Yu, F., Gong, W., Liu, Y., Jiang, B., Tang, T., Patel, R., Platanias, L. C., James, C. D., Stupp, R., Lukas, R. V., Binder, D. C. & 1 others, , Jun 1 2018, In : Clinical Cancer Research. 24, 11, p. 2559-2573 15 p.Research output: Contribution to journal › Article
Glioblastoma
Radiation
Survival
T-Lymphocytes
Therapeutics
Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma
Binder, D. C., Ladomersky, E., Lenzen, A., Zhai, L., Lauing, K. L., Otto-Meyer, S. D., Lukas, R. V. & Wainwright, D. A., Apr 1 2018, In : Translational Cancer Research. 7, p. S510-S513Research output: Contribution to journal › Editorial
Glioblastoma
Therapeutics
epidermal growth factor receptor VIII
rindopepimut
Pediatric Central Nervous System Tumor Diagnosis, Complications, and Emergencies
Lenzen, A., Garcia-Sosa, R., Habiby, R. L., DiPatri, A. J. & Pillay Smiley, N., Jun 1 2018, In : Clinical Pediatric Emergency Medicine. 19, 2, p. 153-161 9 p.Research output: Contribution to journal › Article
Central Nervous System Neoplasms
Emergencies
Pediatrics
Neurogenic Diabetes Insipidus
Neoplasms